Merus Labs, A Specialty Pharmaceutical Company On the Rise, CEO Clip Video

Vancouver, British Columbia--(Newsfile Corp. - June 24, 2016) - Barry Fishman, President & CEO of Merus Labs (TSX: MSL) explains how this specialty pharmaceutical company has products in 34 countries.

If you cannot view the video above, please visit:
http://www.b-tv.com/merus-labs-ceo-clip/

Merus Labs is being featured on CBC's Documentary Channel, Monday through Friday, throughout the day and evenings.

Merus Labs (TSX: MSL)

The Merus strategy is driven by an opportunistic, but highly disciplined approach to source product acquisition candidates. This approach allows Merus to source established pharmaceutical products across broad therapeutic categories. They target underdeveloped assets and optimize their return through cost efficiencies, price opportunities and promotional efforts which drive volume growth. Their geographic focus is North America and Europe. http://www.meruslabs.com/

About CEO Clips:

CEO Clips is the largest library of publicly traded company CEO videos in the US and Canada.  These 90 second video profiles broadcast on national TV and are distributed online on top financial portals including: Thomson Reuters, BNN.ca, and Stockhouse.com.  They are also disseminated via a video news release to several financial portals including Globe Investor, OTC Markets, TMX Money, and The National Post.

BTV - Business Television/CEO Clip Contact: Trina Schlingmann (604) 664-7401 x 5 trina@b-tv.com